We report two patients who developed serum sickness and leukocytoclastic vasculitis following intra-coronary streptokinase therapy for acute myocardial infarction. Additional experience is needed to establish a relationship between streptokinase and serum sickness, and any adverse impact it may have on management of patients with evolving acute myocardial infarction.
|Original language||English (US)|
|Number of pages||6|
|Journal||Current Therapeutic Research - Clinical and Experimental|
|State||Published - Dec 1 1984|
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)